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Overview 
• Global Vaccine Action Plan 
• Measles and Rubella Strategic Plan and Vision  
• Measles and Rubella Targets 
• Progress toward Measles Elimination 
 
GVAP approved by the World Health Assembly in 2012 
“With strong partnerships, resources and political will, we can, 
and must work together to achieve and maintain the 
elimination of measles, rubella and CRS globally” 
 
Margaret Chan, DG, WHO 
Anthony Lake, Executive Director, UNICEF 
Timothy E. Wirth, President, UNF 
Gail J. McGovern, President & CEO, ARC 
Thomas R. Frieden, Director, CDC 
 
THE MEASLES & RUBELLA INITIATIVE:  
GLOBAL MEASLES AND RUBELLA 
 STRATEGIC PLAN 
2012–2020 
Vision 
Achieve and maintain a world 
without measles, rubella and 
congenital rubella syndrome 
Measles and Rubella Targets 
Global targets by 2015: 
Measles vaccination coverage ≥ 90% national and ≥ 80% district 
Measles reported incidence <5 cases per million 
Measles mortality reduction of 95% vs. 2000  
 Global Vaccine Action Plan (GVAP): 
 Measles and rubella elimination in 5 WHO regions by 2020 
Regional targets: 
Measles Elimination goals set: 
2000   AMRO  
2012   WPRO 
2015   EURO, EMRO 
2020   AFRO, SEARO 
Rubella Elimination goals set:  



















































Number of cases MCV1 Coverage*
94% Reduction in reported measles cases 
Measles global annual reported cases and MCV1 coverage*, 1980-2012 




















90% Reduction in Estimated Measles Deaths,  
1985–2012 
Source: WHO/IVB estimates, February 2014 
During 2000–2012 
• 77% decrease in incidence 
• 78% decline in deaths 
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 Measles Catch-up campaigns 
















Reported Measles and Rubella Cases and Measles Vaccination 
Coverage among Infants, Region of the Americas, 1980–2012 






















Global AFR SEAR EMR AMR EUR WPR
Global MCV1 Coverage at 84% in 2012 
Source: WHO/UNICEF coverage estimates 2012 revision. July 2013; Immunization Vaccines and Biologicals, (IVB), World Health Organization. Date of slide: 17 July 2013 
<50%   (3 countries  or 2%) 
50-79%   (32 countries  or 16%) 
80-89%   (31 countries  or 16%) 
>= 90%   (128 countries  or 66%) 
Not available 
Not applicable 
Routine Measles Second Dose  
Not Available, Not Introduced /No Plans (40 countries or 20%) 
Not applicable 
Planned introductions in 2014 (5 countries or 3%) 
Introduced to date (149 countries or 77%) 
• Global MCV2 coverage 56% 
in 2012 
• Increasing number of 
countries with MCV2 
– 145 in 2012 
– 149 in 2013 
– 5 more planned for 2014 
• Important opportunity for 
establishing child health 
platform beyond first-year of 
life, vaccine catch-up 
44 Measles Campaigns in 33 Countries in 2013 
Not Applicable 
Not Available 
 Measles (10) 
Measles and OPV (11) 
Measles and Rubella (10) 
Measles, Rubella and OPV (2) Vitamin A – 14 
De-worming – 12 
Other interventions – 5 
Updated on 13 March 2014 
197 million children reached 
24 (55%) achieved ≥95% coverage 
36 of 44 SIAs 
integrated 1 or 
more other 
interventions 
Global Measles and Rubella Laboratory Network:  
711 Laboratories in 2013 
N= 690 labs  
+ 331 Prefect. Labs 
2012 
Provincial Labs China 
   Global Specialised Labs  
   National Laboratories  
   Regional Reference Labs 
Sub-National Labs 
191/194 countries 
served by proficient 
labs  
10 Sub-National Labs 
 34 Prov. Labs 
Not applicable 
Of 24 known genotypes, 
8 were detected.  
Distribution of Measles Virus Genotypes,  
Apr 2013–Mar 2014 
Source: MeaNS Database as of 21 May 2014 
Measles Case Distribution by Month and WHO Regions, 
2008–2014 
This is surveillance data, hence for the last month, the data may be incomplete.  
SEAR  India is not included in this graph. 
As of 27 May 2013, South Sudan has reassigned to the Africa region (AFR) from the Eastern Mediterranean region (EMR). Data source: surveillance DEF file 
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Reported Measles Incidence Rate*, May 2013 to Apr 2014 
(12M period) 
*Rate per 1'000'000 population 
Data source: surveillance DEF file 
Data in HQ as of 10 June 2014 
No data reported  
to WHO HQ 
<1 (83 countries or 43%) 
≥1 - <5 (28 countries or 14%) 
≥5 - <10 (11 countries or 6%) 
≥10 - <50 (43 countries or 22%) 
≥50 (14 countries or 7%) 
(15 countries or 8%) 
Not applicable 
Measles Cases by Month of Rash Onset, Philippines, 
2009–2014* 
• 26,053 suspected measles cases, including 6,050 lab-confirmed  
• 42% of confirmed cases were in Metro Manila (National Capital 
Region) 
• Majority of cases among children <5 years of age who were 
unvaccinated or with unknown vaccination status 
• >100 reported measles deaths 
19 
THANK YOU! 
